CONTEXT: Screening for ocular manifestations of @entity1778 , although not a routine practice, is important as they may antedate @entity262 or form an isolated focus of its relapse. AIMS: This study evaluates the spectrum of ocular manifestations in @entity3052 presenting to a tertiary care center in India. SETTINGS AND DESIGN: Subjects of @entity1778 presenting to a tertiary care center in India. SUBJECTS AND METHODS: A prospective, cross-sectional study looking at the spectrum of ocular manifestations in all inpatients of @entity3052 . STATISTICAL ANALYSIS USED: The collected data were analyzed using the Statistical Package for Social Sciences for Windows software, version 16 (SPSS Inc., Chicago, Illinois, USA). RESULTS: The study subjects (n = 96) comprised 61 males and 35 females whose age ranged from 18 months to 91 years (mean = 39.73,   22.1). There were 79 adults and 17 @entity1 , 53 new and 43 existing @entity1 , 68 acute and 28 chronic, 61 myeloid and 35 lymphoid @entity1 . @entity3217 were found in 42 @entity1 (43.8%). The ocular manifestations of @entity1778 were significantly (P = 0.01467) more frequent in acute 35/68 (51.9%) than chronic 7/28 (25%) @entity1778 . @entity2617 was seen in 8 (8.3%) subjects while secondary or indirect involvement due to @entity417 , @entity882 , hyperviscosity, total body irradiation, and immunosuppression were seen in 42 (43.8%) subjects. Ocular changes were present in 37/79 (46.8%) adults and 5/17 (29.4%) @entity1 (P = 0.09460). Twenty-eight males (28/61) 45.9% and 14/35 (40%) females had ocular manifestations (P = 0.2874). The ocular manifestations were significantly (P = 0.01158) more frequent in @entity2800 32/61 (52.9%) than @entity706 10/35 (28.6%). CONCLUSIONS: @entity75 were found in 42/96 (43.8%) @entity1 . Ocular involvement is more often seen in adults, acute and @entity2800 . All the primary @entity1778 manifestations were seen in males. A periodic ophthalmic examination should be mandatory for all @entity1778 @entity1 , as ocular changes are often picked up in asymptomatic @entity1 .

Ophthalmic manifestations of XXXX presenting to a tertiary care center in India.

@entity1 :: ('9606', 'Species') :: ['children', 'patients'] @entity417 :: ('MESH:D000740', 'Disease') :: ['anemia'] @entity3217 :: ('MESH:D015821', 'Disease') :: ['Ocular lesions'] @entity882 :: ('MESH:D013921', 'Disease') :: ['thrombocytopenia'] @entity2617 :: ('MESH:D017254', 'Disease') :: ['Primary or direct leukemic infiltration'] @entity706 :: ('MESH:D008223', 'Disease') :: ['lymphoid leukemias'] @entity75 :: ('MESH:D001927', 'Disease') :: ['Leukemic ophthalmic lesions'] @entity262 :: ('MESH:D034721', 'Disease') :: ['systemic disease'] @entity2800 :: ('MESH:D007951', 'Disease') :: ['myeloid leukemias'] @entity3052 :: ('MESH:D015470', 'Disease') :: ['acute or chronic leukemia', 'acute and chronic leukemias'] @entity1778 :: ('MESH:D007938', 'Disease') :: ['leukemias', 'leukemic', 'leukemia']
@entity3052 :: (MESH:D015470,Disease) :: ['acute and chronic leukemias']
